These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18721816)
1. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark Agouti (DA) rats. Zhu CS; Hu XQ; Xiong ZJ; Lu ZQ; Zhou GY; Wang DJ Life Sci; 2008 Sep; 83(11-12):404-12. PubMed ID: 18721816 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Tham E; Gielen AW; Khademi M; Martin C; Piehl F Scand J Immunol; 2006 Dec; 64(6):609-22. PubMed ID: 17083617 [TBL] [Abstract][Full Text] [Related]
3. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Afuwape AO; Feldmann M; Paleolog EM Gene Ther; 2003 Nov; 10(23):1950-60. PubMed ID: 14528319 [TBL] [Abstract][Full Text] [Related]
5. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462 [TBL] [Abstract][Full Text] [Related]
6. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo. Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483 [TBL] [Abstract][Full Text] [Related]
7. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Ohtani K; Egashira K; Hiasa K; Zhao Q; Kitamoto S; Ishibashi M; Usui M; Inoue S; Yonemitsu Y; Sueishi K; Sata M; Shibuya M; Sunagawa K Circulation; 2004 Oct; 110(16):2444-52. PubMed ID: 15477409 [TBL] [Abstract][Full Text] [Related]
8. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650 [TBL] [Abstract][Full Text] [Related]
9. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958 [TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of soluble vascular endothelial growth factor receptor-1 eukaryotic expression vector and its effect on proliferation of vascular endothelial cells]. Ji L; Mao S; Liu H; Xu S; Yang Y; Yi C; Huang Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):369-72. PubMed ID: 20481321 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of human colon cell line Lovo transfected with soluble vascular endothelial growth factor receptor 1 gene]. Zheng CX; Wu RY; Chen LH; Tan M Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):416-9. PubMed ID: 19598033 [TBL] [Abstract][Full Text] [Related]
13. [Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization]. Mi J; Wang JH; Chen SS Ai Zheng; 2002 May; 21(5):464-8. PubMed ID: 12452033 [TBL] [Abstract][Full Text] [Related]
14. Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts. Gao ZN; Wei YQ; Yang PS; Xu X; Zhao HQ; Huan X; Kang B Oral Oncol; 2007 May; 43(5):477-83. PubMed ID: 16997614 [TBL] [Abstract][Full Text] [Related]
15. [Study of adenovirus-mediated vascular endothelial growth factor 165 gene transfer into bone marrow stromal cells and its expressive product promoting proliferation of endothelial cells]. Xiao HB; Mei J; Zhang BR; Huang SD Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):92-6. PubMed ID: 15771811 [TBL] [Abstract][Full Text] [Related]
16. [Construction of adenoviral vector encoding human VEGF(121) cDNA and its expression in vitro]. Cai S; Ma Q; Yu X; Dang G; Ma D Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):379-82. PubMed ID: 12133348 [TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor. Huckle WR; Roche RI J Cell Biochem; 2004 Sep; 93(1):120-32. PubMed ID: 15352169 [TBL] [Abstract][Full Text] [Related]
18. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA; Welsh ME; Carter DE; Karlik SJ J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483 [TBL] [Abstract][Full Text] [Related]
19. [In vitro study of human multiple myeloma cell transfected with soluble vascular endothelial growth factor receptor-1 gene]. Zheng D; Li J; Liu JR; Zhou ZH; Gu JL Chin J Cancer; 2010 Jan; 29(1):65-8. PubMed ID: 20038313 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. Deng X; Szabo S; Khomenko T; Jadus MR; Yoshida M J Pharmacol Exp Ther; 2004 Dec; 311(3):982-8. PubMed ID: 15302893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]